Speaker Profile
Heinz Ulrich Feldmann

Heinz Ulrich Feldmann MD, PhD

Virology, Infectious Disease
Hamilton, Montana, United States of America

Connect with the speaker?

Heinz Feldmann graduated from medical school in 1987 (M.D.) and received his Ph.D. in 1988, both from the University of Marburg, Germany. His postdoctoral research was conducted in the field of virology (filoviruses and hantaviruses) at the Institute of Virology, University of Marburg, Germany, and the special pathogens branch at the Centers for Disease Control and Prevention in Atlanta, where he held a fellowship from the National Research Council. Following his postdoctoral training, he was an assistant and associate professor with the Institute of Virology at the University of Marburg, Germany. During this time, he was trained as an infectious disease specialist with a focus on laboratory diagnostics. From 1999 to 2008, Dr. Feldmann held the position of chief of the special pathogens program of the National Microbiology Laboratory, Public Health Agency of Canada. Since 2008, he has been the chief of the Laboratory of Virology and the chief scientist at the RML BSL-4 laboratories. In addition, he is an associate professor with the department of medical microbiology at, University of Manitoba.

Dr. Feldmann is a laboratory expert on high containment viruses (BSL-4) and serves as a consultant on viral hemorrhagic fevers and related pathogens for the World Health Organization and, thus, has field experience and expertise in outbreak management. He is a member of national and international professional societies and serves on the editorial board of several journals, as well as being an invited reviewer for multiple journals from related fields. Dr. Feldmann is an external scientific reviewer for national and international organizations and serves as a scientific consultant for high containment laboratories. His professional interest is in the pathogenesis of hemorrhagic fever viruses, such as filoviruses, arenaviruses, a nd bunyaviruses, and other emerging viral pathogens (containment level BSL-3 and BSL-4) and the development of countermeasures against those pathogens.

EVENTS & ACTIVITIES (Speaking, Spoken, and Authored)